ACM
ANIP icon

Ativo Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Ativo Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-23,006
Closed -$1.3M – 121
2018
Q3 		$1.3M Sell
23,006
-2,001
-8% -$122K 0.35% 105
2018
Q2 		$1.67M Hold
25,007
– – 0.46% 51
2018
Q1 		$1.46M Sell
25,007
-4,002
-14% -$254K 0.41% 76
2017
Q4 		$1.87M Buy
29,009
+2
+0% +$124 0.5% 40
2017
Q3 		$1.52M Buy
29,007
+3,002
+12% +$143K 0.41% 81
2017
Q2 		$1.22M Buy
26,005
+10,200
+65% +$492K 0.33% 125
2017
Q1 		$783K Hold
15,805
– – 0.19% 202
2016
Q4 		$958K Hold
15,805
– – 0.23% 177
2016
Q3 		$1.05M Sell
15,805
-800
-5% -$50K 0.24% 140
2016
Q2 		$927K Buy
16,605
+3,600
+28% +$175K 0.23% 137
2016
Q1 		$438K Buy
13,005
+1,500
+13% +$50.9K 0.12% 170
2015
Q4 		$519K Buy
11,505
+1,300
+13% +$56K 0.13% 148
2015
Q3 		$436K Buy
10,205
+1,001
+11% +$56.9K 0.12% 194
2015
Q2 		$513K Buy
9,204
+1,589
+21% +$94.6K 0.18% 134
2015
Q1 		$476K Buy
+7,615
New +$463K 0.19% 134

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ativo Capital Management's ANIP Position: Q4 2018 in Review

Ativo Capital Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2018, closing a stake of 23,006 shares — an estimated $1.3M sold.

Ativo Capital Management first reported a position in ANIP in Q1 2015 and held it in 15 quarters. The position peaked at $1.87M in Q4 2017. 170 funds tracked by Wall St. Rank hold ANIP as of Q4 2018.

  • Ativo Capital Management reported no remaining ANI Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Ativo Capital Management sold 23,006 ANI Pharmaceuticals shares in Q4 2018, an estimated $1.3M.
  • Ativo Capital Management first reported a position in ANI Pharmaceuticals in Q1 2015 and held it in 15 quarters.
  • Ativo Capital Management's ANI Pharmaceuticals position peaked at $1.87M in Q4 2017.
  • 170 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2018.

Based on Ativo Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.